New Features and Changes From the Previous American Association for the Study of Liver Diseases Guidelines
- An overview of the current understanding of bleeding and thrombosis in cirrhosis.
- An evidence‐based justification for bleeding risk assessment in patients with cirrhosis before invasive procedures, including current concepts in preprocedural testing and laboratory analysis and their role in predicting bleeding complications.
- An outline of established and recently identified risk factors for venous thrombosis in the portal and hepatic venous systems in both patients with and without cirrhosis along with thrombophilia testing recommendations.
- A review of the strengths and weaknesses of the various classification systems for portal vein thrombosis and a proposal for standard nomenclature regarding characterization of portal vein thrombosis location, time course, and progression.
- A comprehensive review of procedural and medical therapies for treatment of portal vein thrombosis including the use of direct oral anticoagulants.
- A step‐by‐step treatment and surveillance algorithm for portal vein thrombosis in patients with cirrhosis.
- Updated diagnostic, treatment, and management recommendations for sinusoidal obstruction syndrome, hereditary hemorrhagic telangiectasia, and hepatic vein thrombosis.
- Classification and management recommendations for idiopathic noncirrhotic portal hypertension and the portosinusoidal vascular disorders.
- Surveillance and evaluation recommendations for hepatic and splenic artery aneurysms.
- A review of the management issues in vascular liver disorders specific to children and guidance on early intervention in extrahepatic portal vein obstruction in children.

